Literature DB >> 19903011

Glucagon receptor mediates calcium signaling by coupling to G alpha q/11 and G alpha i/o in HEK293 cells.

Yazhen Xu1, Xin Xie.   

Abstract

Glucagon induces intracellular Ca(2+) ([Ca(2+)](i)) elevation by stimulating glucagon receptor (GCGR). Such [Ca(2+)](i) signaling plays important physiological roles, including glycogenolysis and glycolysis in liver cells and the survival of beta-cells. Previous studies indicated that phospholipase C (PLC) might be involved in glucagon-mediated [Ca(2+)](i) response. Other studies also debated whether cAMP accumulation mediated by GCGR/G alpha(s) coupling contributes to [Ca(2+)](i) elevation. But the exact mechanisms remain uncertain. In the present study, we found that glucagon induces [Ca(2+)](i) elevation in HEK293 cells expressing GCGR. Removing extracellular Ca(2+) did not affect glucagon-stimulated [Ca(2+)](i) response. But depleting the intracellular Ca(2+) store by thapsigargin completely inhibited glucagon-induced [Ca(2+)](i) response. Experiments with forskolin and adenylyl cyclase inhibitor revealed that cAMP is not the cause of [Ca(2+)](i) response. Further studies with G alpha(q/11) RNAi and pertussis toxin (PTX) indicated that both G alpha(q/11) and G alpha(i/o) are involved. Combination of G alpha(q/11) RNAi and G alpha(i/o) inhibition almost completely abolished glucagon-induced [Ca(2+)](i) signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903011     DOI: 10.3109/10799890903295150

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

1.  Glucagon regulates ACC activity in adipocytes through the CAMKKβ/AMPK pathway.

Authors:  I-Chen Peng; Zhen Chen; Wei Sun; Ying-Shiuan Li; Traci LaNai Marin; Pang-Hung Hsu; Mei-I Su; Xiaopei Cui; Songqin Pan; Christian Y Lytle; David A Johnson; Frank Blaeser; Talal Chatila; John Y-J Shyy
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

Review 2.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

3.  Pancreatic α and β cells are globally phase-locked.

Authors:  Huixia Ren; Yanjun Li; Chengsheng Han; Yi Yu; Bowen Shi; Xiaohong Peng; Tianming Zhang; Shufang Wu; Xiaojing Yang; Sneppen Kim; Liangyi Chen; Chao Tang
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

4.  The Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity.

Authors:  Junfeng Han; Ming Zhang; Sean Froese; Feihan F Dai; Mélanie Robitaille; Alpana Bhattacharjee; Xinyi Huang; Weiping Jia; Stéphane Angers; Michael B Wheeler; Li Wei
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

5.  Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2).

Authors:  Cathryn Weston; Jing Lu; Naichang Li; Kerry Barkan; Gareth O Richards; David J Roberts; Timothy M Skerry; David Poyner; Meenakshi Pardamwar; Christopher A Reynolds; Simon J Dowell; Gary B Willars; Graham Ladds
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

6.  Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure.

Authors:  Chen Gao; Shuxun Vincent Ren; Junyi Yu; Ulysis Baal; Dung Thai; John Lu; Chunyu Zeng; Hai Yan; Yibin Wang
Journal:  JACC Basic Transl Sci       Date:  2019-03-13

7.  Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.

Authors:  Weidong Zhang; Hideyuki Sakoda; Yuki Nakazato; Md Nurul Islam; François Pattou; Julie Kerr-Conte; Masamitsu Nakazato
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

8.  Signal Transduction Mechanisms for Glucagon-Induced Somatolactin Secretion and Gene Expression in Nile Tilapia (Oreochromis niloticus) Pituitary Cells.

Authors:  Chaoyi Zhang; Anji Lian; Yue Xu; Quan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-04       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.